Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-01-25 4:05 pm | N/A 2034-01-23 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 300,000 | $3.06 | 300,000 (Direct) | View |
| 2023-08-17 Gift | 2023-08-18 4:03 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 63,000 | $0 | 511,704 (Direct) | View |
| 2023-05-26 Gift | 2023-05-31 9:22 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 300,000 | $0 | 448,704 (Indirect) | View |
| 2022-10-25 Other | 2023-02-22 4:23 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 189,310 | $0 | 890,324 (Direct) | View |
| 2022-02-10 Gift | 2023-02-22 4:23 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 127,850 | $0 | 890,324 (Direct) | View |
| 2023-01-26 Option Award | 2023-01-30 5:02 pm | N/A 2033-01-25 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 280,000 | $0 | 280,000 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-19 4:06 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 40,000 | $0.54 | 930,629 (Direct) | View |
| 2022-09-16 Exercise | 2022-09-19 4:06 pm | N/A 2027-05-29 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 40,000 | $0 | 930,629 (Direct) | View |
| 2022-01-26 Option Award | 2022-01-28 4:26 pm | N/A 2032-01-25 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 440,000 | $0 | 911,704 (Direct) | View |
| 2021-08-20 Exercise | 2021-08-23 5:01 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 23,000 | $0.54 | 930,629 (Direct) | View |
| 2021-08-20 Exercise | 2021-08-23 5:01 pm | N/A 2027-05-29 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN Chief Executive Officer | 23,000 | $0 | 930,629 (Direct) | View |
| 2021-01-28 Option Award | 2021-02-01 9:23 pm | N/A 2031-01-27 | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks | 300,000 | $0 | 300,000 (Direct) | View |
| 2020-10-27 Conversion | 2020-10-29 4:59 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks | 50,450 | $0 | 25,225 (Indirect) | View |
Ownership | 2020-10-22 8:45 pm | N/A N/A | Foghorn Therapeutics Inc. | FHTX | GOTTSCHALK ADRIAN See Remarks | 0 | $0 | 1,492,136 (Direct) | View |